Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for INSULIN DETEMIR
- A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It
- DETERMINE: Detemir vs NPH
- MeDiGes Study: Metformine Use in Gestational Diabetes
- Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes
- Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
- Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
- Environmental Effects Type 1 Diabetes Mellitus
- Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal Insulin
- Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)
- Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes
- Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
- Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
- A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin
- A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral An
- A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
- The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
- An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
- A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Withou
- Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1
- Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
- Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients
- Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
- Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes
- Insulin Therapy for Post-transplant Glucocorticoid Induced Hyperglycemia
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)
- Efficacy and Safety of Levemir® Used as Basal Insulin
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days
- Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
- Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
- The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
- Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
- Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes
- An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
- A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus
- Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects
- Comparison of Two Insulin Detemir Formulations in Healthy Volunteers
- Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
- Pharmacokinetics of Insulin Detemir in Healthy Volunteers From Taiwan
- Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes
- Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes
- Within-subject Variability of Insulin Detemir in Healthy Volunteers
- Comparison of Insulin Detemir Produced by the Current Process and the NN729 Process in Healthy Subjects
- An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime
- Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
- Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
- Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
- Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes
- The Effects of Insulin Detemir and Gliclazide-MR Treatments on Endothelial Functions in Patients With Type 2 Diabetes
- A Comparison of Two Initial Dosing Formulas
- Management of Type-2 Diabetic Patients Treated With Insulin During the Ramadan
- Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin
- Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
- Insulin Detemir in Obesity Management
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes
- Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
- A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes
- Cystic Fibrosis - Insulin Deficiency, Early Action
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment
- Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
- Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs
- The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin
- INSUlin Regimens and VASCular Functions
- Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
- Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
- Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
- Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes
- Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin
- Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes
- Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin
- Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
- Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
- Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication
- Observational Study in Type 2 Diabetics Failing on Oral Antidiabetic Therapy and Starting on Insulin Treatment
- Levemir-Body Composition and Energy Metabolism
- The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes
- Observational Study on Levemir® in Obese Diabetic Patients
- Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia
- An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries
- Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes
- Observational Study to Evaluate the Safety of Levemir® in Type 2 Diabetes
- A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
- Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
- Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment
- Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
- An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes
- Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes
- Detemir Energy Expenditure Study
- Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes
- Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia
- Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
- Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients
- Observational Study on Safety of Self-titration of Once Daily Levemir®
- An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
- Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes
- Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir
- Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents
- Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
- Observational Safety Study in Subjects Using Levemir® (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus
- Observational Study to Evaluate the Safety of Levemir® in Diabetes
- Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes
- Observational Study to Evaluate the Safety While Using Levemir®
- Observational Study Describing Conditions for Administering Slow-acting Insulin Analogue With Oral Antidiabetic Agents in Type 2 Diabetes on Blood Glucose Control
- Observational Study to Evaluate the Safety and Efficacy of Levemir® in Type 2 Diabetes
- Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
- Endothelial Effects of Basal Insulin: Detemir Versus Glargine
- An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment
- Observational Study on the Weight Effect of Insulin Detemir (Levemir®) in Type 2 Diabetics
- Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
- Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
- Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin
- Observational Study of Patients With Diabetes Using Levemir® FlexPen®
- Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
- Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
- Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
- Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care
- Observational Study to Evaluate the Safety of Levemir® in Diabetes
- Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
- Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®
- The Copenhagen Insulin and Metformin Therapy Trial
- Observational Study in Type 2 Diabetes Treated by an Intensive Insulin Treatment (ICT) Containing Once Daily Levemir® (Insulin Detemir)
- Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine
- Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
- Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
- Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily
- Insulin Detemir Action in Cerebro
- Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
- Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes
- Safety of Insulin Detemir in Children With Type 1 Diabetes
- Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes
- Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes
- Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone
- Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
- Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes
- Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.
- Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
- Basal Insulins - Pharmacodynamics
- Detemir: Role in Type 1 Diabetes
- Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
- Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial
- Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections
- Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
- Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
- The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD
- Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
- Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
- Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
- Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
- Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
- Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
- Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
- A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
- Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes
- Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
- Lantus Versus Levemir Treat-To-Target
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes
- Insulin Analogues and Severe Hypoglycaemia
- Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
- Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
- Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
- Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
- Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
- Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
- Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients
- Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
- Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
- Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes
- Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes
- Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes
- Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
- Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes
- Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes
- Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
Clinical trials list
click for details